Mutations in genes <i>lpxL1</i> , <i>bamA</i> , and <i>pmrB</i> impair the susceptibility of cystic fibrosis strains of <i>Pseudomonas aeruginosa</i> to murepavadin
Aya Ghassani(Centre National de la Recherche Scientifique), Patricia Mariani(Hôpital Robert-Debré), Vincent Cattoir(Inserm), Thomas Guillard(Centre Hospitalier Universitaire de Reims), Maxime Bour(CNR de la Résistance aux Antibiotiques), Fabien Garnier(Inserm), Lise Crémet(Centre Hospitalier Universitaire de Nantes), Hélène Guet‐Revillet(Université Toulouse III - Paul Sabatier), Pauline Triponney(Centre Hospitalier Universitaire de Besançon), Katy Jeannot(Centre National de la Recherche Scientifique), Patrick Plésiat(Hôpital Ambroise-Paré), Anne Doléan-Jordheim(Hôpital Necker-Enfants Malades), Agnès Ferroni(Hôpital Necker-Enfants Malades), Geneviève Héry-Arnaud(Centre Hospitalier Régional Universitaire de Brest), Guenièvre Imbert(Hôpital Robert-Debré), Émilie Cardot-Martin(Centre Hospitalier Universitaire de Rennes)
Cited by 8
Related Papers
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
|Clinical Microbiology and Infection|2007|575
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
|Science|2020|382
Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature
|Drug Resistance Updates|2018|283
Characterization of transposon Tn1549, conferring VanB-type resistance in Enterococcus spp. The GenBank accession number for the 33803 bp sequence of Tn1549 is AJ192329.
|Microbiology|2000|168
Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases
|Clinical Microbiology and Infection|2018|146